Markets Earnings Screener Watchlist

Fundamentals and filings are sourced from SEC EDGAR. Market data, ownership and analyst consensus are sourced from Nasdaq. Written analysis is generated by metir from those sources and the linked reporting.

All information is provided for informational purposes only. It is not investment, financial, tax or legal advice, is not a recommendation to buy or sell any security, and is not intended for trading purposes. Data may be delayed or incomplete.

Markets open

Medline Inc. Stock Price: Quote, Financials, Forecast & News (MDLN)

Medline Inc.

MDLN · Nasdaq

Overview Financials Earnings Holders Historical Data Analysis

Symbol: MDLN
Type: Stock
Sector: Health Care
Industry: Medical/Dental Instruments
Country: North America
Exchange: Nasdaq

Medline is the largest provider of medical-surgical products and supply chain solutions serving all points of care. Through its broad product portfolio, resilient supply chain and leading clinical solutions, Medline helps healthcare providers improve their clinical, financial and operational outcomes. Headquartered in Northfield, Ill., the company employs more than 45,000 people worldwide and operates in more than 100 countries. To learn more about how Medline makes healthcare run better, visit www.medline.com.

Analyst Consensus

Buy

0 analysts

$36

Current

—

Low

$52

Average

—

High

Average target implies +44.32% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Edwards Lifesciences CorporationEW · NYSE$88.740.96%
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of

TAK · NYSE

$16.590.18%

argenx SE American Depositary SharesARGX · NASDAQ-GS$864.132.32%

Cardinal Health, Inc.CAH · NYSE$237.561.72%

$36.03-$5.9914.25%

As of: Aug 5, 2:36 PM

Prev Close: $42.04
Market Cap: $47.33B
Open: —
Trailing P/E: —
Day Range: $37.98 - $35.70
52W Range: $50.88 - $32.82
Forward P/E: —
EPS: —
Volume: 5.45M
Dividend Yield: —

Notable Price Movement

Weekly movement commentary will appear here once it has been generated for this company.

Stories & Analysis

Why Symbotic Stock Dropped 24% in the First Half of 2026 And Is a Screaming Buy Now

The Motley Fool · Jul 23

ICUI or MDLN: Which Is the Better Value Stock Right Now?

Zacks · Jun 18

Why Symbotic Stock Slumped 21% in May And Just Hit a 2026 Low

The Motley Fool · Jun 8

Stocks Climb on Lower Bond Yields and Chipmaker Strength

Barchart · May 20

Stocks Rally as Crude Oil and Bond Yields Slump

Barchart · May 20 Medline (MDLN) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks · May 7 MDLN Gets FDA Warning for Quality Lapses in Angiographic Syringes

Zacks · Apr 14 Medline (MDLN) Price Target Increased by 13.24% to 54.65

Fintel · Mar 27

Beta

—

Avg Volume

9.57M